BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31724824)

  • 1. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.
    Cyrus S; Burkardt D; Weaver DD; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EED related overgrowth: First report of multiple members in a single family.
    Goel H; O'Donnell S; Edwards M
    Am J Med Genet A; 2024 Feb; 194(2):374-382. PubMed ID: 37840385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.
    Imagawa E; Higashimoto K; Sakai Y; Numakura C; Okamoto N; Matsunaga S; Ryo A; Sato Y; Sanefuji M; Ihara K; Takada Y; Nishimura G; Saitsu H; Mizuguchi T; Miyatake S; Nakashima M; Miyake N; Soejima H; Matsumoto N
    Hum Mutat; 2017 Jun; 38(6):637-648. PubMed ID: 28229514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndrome.
    Griffiths S; Loveday C; Zachariou A; Behan LA; Chandler K; Cole T; D'Arrigo S; Dieckmann A; Foster A; Gibney J; Hunter M; Milani D; Pantaleoni C; Roche E; Sherlock M; Springer A; White SM; ; Tatton-Brown K
    Am J Med Genet A; 2019 Apr; 179(4):588-594. PubMed ID: 30793471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare SUZ12 variants commonly cause an overgrowth phenotype.
    Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.
    Choufani S; Gibson WT; Turinsky AL; Chung BHY; Wang T; Garg K; Vitriolo A; Cohen ASA; Cyrus S; Goodman S; Chater-Diehl E; Brzezinski J; Brudno M; Ming LH; White SM; Lynch SA; Clericuzio C; Temple IK; Flinter F; McConnell V; Cushing T; Bird LM; Splitt M; Kerr B; Scherer SW; Machado J; Imagawa E; Okamoto N; Matsumoto N; Testa G; Iascone M; Tenconi R; Caluseriu O; Mendoza-Londono R; Chitayat D; Cytrynbaum C; Tatton-Brown K; Weksberg R
    Am J Hum Genet; 2020 May; 106(5):596-610. PubMed ID: 32243864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of maternal EED results in postnatal overgrowth.
    Prokopuk L; Stringer JM; White CR; Vossen RHAM; White SJ; Cohen ASA; Gibson WT; Western PS
    Clin Epigenetics; 2018 Jul; 10(1):95. PubMed ID: 30005706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder.
    Imagawa E; Seyama R; Aoi H; Uchiyama Y; Marcarini BG; Furquim I; Honjo RS; Bertola DR; Kim CA; Matsumoto N
    Clin Genet; 2023 Apr; 103(4):383-391. PubMed ID: 36645289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty.
    Okamoto N; Yoshida S; Ogitani A; Etani Y; Yanagi K; Kaname T
    Am J Med Genet A; 2024 May; ():e63726. PubMed ID: 38814056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
    Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT
    Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity.
    Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of epilepsy in a patient with EED-related overgrowth (Cohen-Gibson syndrome).
    Hetzelt KLML; Winterholler M; Kerling F; Rauch C; Ekici AB; Winterpacht A; Vasileiou G; Uebe S; Thiel CT; Kraus C; Reis A; Zweier C
    Am J Med Genet A; 2022 Jan; 188(1):292-297. PubMed ID: 34533271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.
    Tatton-Brown K; Murray A; Hanks S; Douglas J; Armstrong R; Banka S; Bird LM; Clericuzio CL; Cormier-Daire V; Cushing T; Flinter F; Jacquemont ML; Joss S; Kinning E; Lynch SA; Magee A; McConnell V; Medeira A; Ozono K; Patton M; Rankin J; Shears D; Simon M; Splitt M; Strenger V; Stuurman K; Taylor C; Titheradge H; Van Maldergem L; Temple IK; Cole T; Seal S; ; Rahman N
    Am J Med Genet A; 2013 Dec; 161A(12):2972-80. PubMed ID: 24214728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
    Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
    Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
    Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
    Zhao Y; Guan YY; Zhao F; Yu T; Zhang SJ; Zhang YZ; Duan YC; Zhou XL
    Eur J Med Chem; 2022 Mar; 231():114144. PubMed ID: 35093670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel SUZ12 mutations in Weaver-like syndrome.
    Imagawa E; Albuquerque EVA; Isidor B; Mitsuhashi S; Mizuguchi T; Miyatake S; Takata A; Miyake N; Boguszewski MCS; Boguszewski CL; Lerario AM; Funari MA; Jorge AAL; Matsumoto N
    Clin Genet; 2018 Nov; 94(5):461-466. PubMed ID: 30019515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three additional patients with EED-associated overgrowth: potential mutation hotspots identified?
    Spellicy CJ; Peng Y; Olewiler L; Cathey SS; Rogers RC; Bartholomew D; Johnson J; Alexov E; Lee JA; Friez MJ; Jones JR
    J Hum Genet; 2019 Jun; 64(6):561-572. PubMed ID: 30858506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.
    Korfhage J; Lombard DB
    Mol Cancer Res; 2019 Jul; 17(7):1417-1428. PubMed ID: 31023785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.